Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe
Medina-Lara, A; Kigozi, J; Amurwon, J; et al.Muchabaiwa, L; Nyanzi Wakaholi, B; Mujica-Mota, Ruben; Walker, AS; Kasirye, R; Ssali, F; Reid, A; Grosskurth, H; Babiker, AG; Kityo, C; Katabira, E; Munderi, P; Mugyenyi, P; Hakim, J; Darbyshire, J; Gibb, DM; Gilks, CF; DART Trial Team
Date: 24 April 2012
Article
Journal
PLoS One
Publisher
Public Library of Science
Publisher DOI
Related links
Abstract
Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity of antiretroviral therapy (ART) have rarely been evaluated.
Institute of Health Research
Collections of Former Colleges
Item views 0
Full item downloads 0